388 related articles for article (PubMed ID: 8665523)
21. Role of astrocyte-derived tissue-type plasminogen activator in the regulation of endotoxin-stimulated nitric oxide production by microglial cells.
Vincent VA; Löwik CW; Verheijen JH; de Bart AC; Tilders FJ; Van Dam AM
Glia; 1998 Feb; 22(2):130-7. PubMed ID: 9537833
[TBL] [Abstract][Full Text] [Related]
22. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration.
Mars WM; Liu ML; Kitson RP; Goldfarb RH; Gabauer MK; Michalopoulos GK
Hepatology; 1995 Jun; 21(6):1695-701. PubMed ID: 7768515
[TBL] [Abstract][Full Text] [Related]
23. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).
Hall CL; Tsan R; Mugnai G; Mazar A; Radinsky R; Pettaway CA
Prostate; 2004 May; 59(2):167-76. PubMed ID: 15042617
[TBL] [Abstract][Full Text] [Related]
24. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
[TBL] [Abstract][Full Text] [Related]
25. The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.
Fawthrop FW; Oyajobi BO; Bunning RA; Russell RG
J Bone Miner Res; 1992 Dec; 7(12):1363-71. PubMed ID: 1481722
[TBL] [Abstract][Full Text] [Related]
26. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
[TBL] [Abstract][Full Text] [Related]
27. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
Fowler B; Mackman N; Parmer RJ; Miles LA
Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
[TBL] [Abstract][Full Text] [Related]
28. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
29. Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor.
Michalopoulos GK; Bowen WC; Zajac VF; Beer-Stolz D; Watkins S; Kostrubsky V; Strom SC
Hepatology; 1999 Jan; 29(1):90-100. PubMed ID: 9862855
[TBL] [Abstract][Full Text] [Related]
30. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
[TBL] [Abstract][Full Text] [Related]
31. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
Roldán-Olarte M; García DC; Jiménez-Díaz M; Valdecantos PA; Miceli DC
Anim Reprod Sci; 2012 Dec; 136(1-2):90-9. PubMed ID: 23103014
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
Reuning U; Bang NU
Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
[TBL] [Abstract][Full Text] [Related]
33. Phenobarbital suppresses growth and accelerates restoration of differentiation markers of primary culture rat hepatocytes in the chemically defined hepatocyte growth medium containing hepatocyte growth factor and epidermal growth factor.
Miyazaki M; Mars WM; Runge D; Kim TH; Bowen WC; Michalopoulos GK
Exp Cell Res; 1998 Jun; 241(2):445-57. PubMed ID: 9637786
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
Colombo ES; Menicucci G; McGuire PG; Das A
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
[TBL] [Abstract][Full Text] [Related]
35. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
Ueshima S; Fukao H; Okada K; Matsuo O
Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
[TBL] [Abstract][Full Text] [Related]
36. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.
Mars WM; Zarnegar R; Michalopoulos GK
Am J Pathol; 1993 Sep; 143(3):949-58. PubMed ID: 8362987
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
Busso N; Belin D; Failly-Crépin C; Vassalli JD
Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
[TBL] [Abstract][Full Text] [Related]
38. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
Glia; 1992; 6(3):163-71. PubMed ID: 1335967
[TBL] [Abstract][Full Text] [Related]
39. Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase.
Corti A; Sarubbi E; Soffientini A; Nolli ML; Zanni A; Galimberti M; Parenti F; Cassani G
Thromb Haemost; 1989 Nov; 62(3):934-9. PubMed ID: 2480654
[TBL] [Abstract][Full Text] [Related]
40. Effects of mitogens and co-mitogens on the formation of small-cell colonies in primary cultures of rat hepatocytes.
Mitaka T; Norioka K; Nakamura T; Mochizuki Y
J Cell Physiol; 1993 Dec; 157(3):461-8. PubMed ID: 8253857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
